Glycoprotein Peptid
Reaktivität: Säugetier
Wirt: Synthetic
BP, IHC, WB
-
- Target
- Glycoprotein
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequenz
- DENDWNEKLY PVWKRGDMRW KNSWKGGRVQ AVLTSDSPAL VGSNITFAVN
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GPNMB antibody,
Alternative Names: Glycoprotein control peptide, Glycoprotein antibody Blocking Peptide, Anti-Glycoprotein Blocking Peptide, HGFIN Blocking Peptide, NMB Blocking Peptide, Transmembrane Nmb Blocking Peptide, GPNMB Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- Glycoprotein
- Synonyme
- glycoprotein Peptide, Glycoprotein Peptide, transmembrane glycoprotein G Peptide, G Peptide, RVFV_sM_gp1 Peptide, RABVgp4 Peptide
- Substanzklasse
- Viral Protein
- Hintergrund
- GPNMB is a type I transmembrane glycoprotein which shows homology to the pMEL17 precursor, a melanocyte-specific protein. GPNMB shows expression in the lowly metastatic human melanoma cell lines and xenografts but does not show expression in the highly metastatic cell lines. GPNMB may be involved in growth delay and reduction of metastatic potential.
- Molekulargewicht
- 60 kDa
-
Sie sind hier:
